Local Institution

Panorama, Western Cape 7506

0 studies enrolling now · 16 studies all time

What they study most

Breast Cancer, Cancer, Colitis, Ulcerative, Crohn's Disease, Metastases, Psoriatic Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus, Ulcerative Colitis

Studies at this site

• Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate — Completed
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) — Completed
• Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis — Completed
• Methotrexate-Inadequate Response Study — Completed
• Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease — Completed
• Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis — Completed
• Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis — Completed
• Phase IIIB Subcutaneous Missed Dose Study — Completed
• A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed
• Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis — Completed
• Phase IIIB Subcutaneous Abatacept Monotherapy Study — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone — Completed
• Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis — Stopped early
• Remission and Joint Damage Progression in Early Rheumatoid Arthritis — Completed